CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 76% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English

Trade Chugai Pharmaceutical Co., Ltd. - 4519 CFD

6848.2
1.19%
Market Trading Hours* (UTC) Opens on Tuesday at 00:00

Tue - Fri: 00:00 - 02:30 03:30 - 06:00

  • Summary
  • Historical Data
Trading сonditions
Spread 25.6
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.011658 %
Charges from full value of position ($-2.22)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.011658%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.010565 %
Charges from full value of position ($-2.01)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.010565%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency JPY
Margin 5.00%
Stock exchange Japan
Commission on trade 0%

Key Stats
Prev. Close 6767.6
Open 6888.3
1-Year Change 55.13%
Day's Range 6847.3 - 6897.1
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Sep 20, 2024 6848.2 -28.1 -0.41% 6876.3 6901.1 6838.4
Sep 19, 2024 6767.6 -68.9 -1.01% 6836.5 6900.2 6767.6
Sep 18, 2024 6717.3 -120.9 -1.77% 6838.2 6845.2 6650.7
Sep 17, 2024 6862.4 7.1 0.10% 6855.3 6872.4 6770.5
Sep 13, 2024 6703.2 -54.1 -0.80% 6757.3 6781.4 6671.6
Sep 12, 2024 6833.2 185.7 2.79% 6647.5 6874.3 6622.4
Sep 11, 2024 6467.6 -138.2 -2.09% 6605.8 6619.6 6429.7
Sep 10, 2024 6585.5 95.1 1.47% 6490.4 6699.0 6476.5
Sep 9, 2024 6533.5 63.9 0.99% 6469.6 6564.5 6388.5
Sep 6, 2024 6584.5 -41.5 -0.63% 6626.0 6752.5 6572.1
Sep 5, 2024 6612.0 -210.8 -3.09% 6822.8 6853.3 6612.0
Sep 4, 2024 6908.1 26.9 0.39% 6881.2 7001.1 6794.9
Sep 3, 2024 7087.8 101.7 1.46% 6986.1 7094.2 6966.7
Sep 2, 2024 6925.1 -382.6 -5.24% 7307.7 7321.7 6922.1
Aug 30, 2024 7368.7 -24.1 -0.33% 7392.8 7432.0 7254.5
Aug 29, 2024 7351.7 3.0 0.04% 7348.7 7408.5 7279.7
Aug 28, 2024 7330.7 -7.7 -0.10% 7338.4 7341.6 7206.5
Aug 27, 2024 7326.7 161.6 2.26% 7165.1 7350.1 7165.1
Aug 26, 2024 7063.2 -2.0 -0.03% 7065.2 7099.1 6844.4
Aug 23, 2024 7216.8 24.0 0.33% 7192.8 7363.8 7128.0

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Chugai Pharmaceutical Co., Ltd. Company profile

About Chugai Pharmaceutical Co Ltd

CHUGAI PHARMACEUTICAL CO., LTD. is a Japan-based company mainly engaged in the research, development, manufacture, sale, import and export of pharmaceutical products. The pharmaceutical products and medical devices for patients include ACTEMRA, Avastin, ALAGLIO, Aresensa, Kadosaira, Gazaiba, Seruseputo, Zeruborafu, Zeroda, Taruseba, Tecentoriku, Pajeta and other products. The products are mainly applied to the treatment of cancer, kidney diseases, kidney transplantation, bone and joint diseases such as rheumatoid arthritis, osteoporosis, knee osteoarthritis and locomotive syndrome, influenza, hemophilia and other diseases. The Company is also engaged in the provision of management services, transportation and storage services, as well as drug information literature research services. The Company operates within the domestic market and to overseas markets, including Switzerland, United Kingdom, Germany, France, China, Singapore, Korea and the United States.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Chugai Pharmaceutical Co Ltd revenues increased 27% to Y999.76B. Net income increased 41% to Y303B. Revenues reflect Net Sales increase of 27% to Y802.84B, Royalties and other operating revenues increase of 28% to Y196.92B. Dividend per share increased from Y55.00 to Y76.00. Basic Earnings per Share excluding Extraordinary Items increased from Y130.66 to Y184.29.

Equity composition

FY'03, the Co. changed FY end from March to December. FY'94-'02 WAS & FY'04 Q1 &Q3 WAs & O/S were estimated. 3/05 & 9/05, WAS, O/S, DPS were estimated. FY'06 Q3 & '07 Q1, Q3 WAS& DWAS were estimated, and its WAS was used as O/S. FY'08 1Q WAS & DWAS were estimated and WAS was used as o/s. FY'08 Q3 WAS estimated and used as o/s.

Industry: Pharmaceuticals (NEC)

日本橋三井タワー15f
日本橋室町2-1-1
CHUO-KU
TOKYO-TO 103-8324
JP

News

RBA Preview: Rates to remain unchanged with inflation-fighting still the focus

RBA Governor Michelle Bullock emphasizes inflation challenges for Australia's economy, citing supply shocks and demand-supply imbalances. Discover insights on CPI trends, interest rates, and the central bank's strategy for managing price pressures in 2024.

12:27, 20 September 2024

BoE Preview: no change expected but forward guidance will be key

The BoE is forecasted to leave rates unchanged in September as UK CPI remains stubborn.

14:53, 19 September 2024

FOMC Decision Review: A 50 point cut but the markets responded in a mixed fashion

Discover the US Federal Reserve’s latest 50 basis point cut and how the markets reacted. Stocks surged, the US Dollar fell, and the Fed hints at more aggressive cuts ahead.

11:30, 19 September 2024

Bank of Japan Preview

The Bank of Japan will meet on September 20, 2024, with markets anticipating minimal policy changes. However, inflation risks remain, with core CPI at 2.7% and potential for future interest rate hikes.

09:40, 17 September 2024

FOMC Decision Preview

As the US Federal Reserve prepares for its most significant decision since ending the rate hike cycle in mid-2023, the balance of risks has shifted. With inflation stabilizing at 2.6% and rising unemployment at 4.2%, the FOMC faces increasing pressure to address employment concerns. Markets anticipate a rate cut, with debate on the extent of the reduction.

09:48, 16 September 2024

ECB Preview: cuts expected but the pace is uncertain

Markets expect the ECB to cut rates again in September, but how many more?

12:34, 11 September 2024

Market analysis: US CPI and PPI

Overview of upcoming US inflation data for August, with expectations for a year-over-year CPI drop to 2.6% and core CPI holding steady at 3.2%. Markets will also focus on U.S. PPI data, which is forecasted to show mild growth, reinforcing potential easing inflationary pressures.

07:56, 10 September 2024

People also watch

US100

19,782.90 Price
-0.180% 1D Chg, %
Long position overnight fee -0.0248%
Short position overnight fee 0.0026%
Overnight fee time 21:00 (UTC)
Spread 7.0

XRP/USD

0.59 Price
-1.560% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 0.01168

BTC/USD

62,980.05 Price
-0.180% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 106.00

Gold

2,622.64 Price
+1.370% 1D Chg, %
Long position overnight fee -0.0181%
Short position overnight fee 0.0099%
Overnight fee time 21:00 (UTC)
Spread 0.60

Still looking for a broker you can trust?

Join the 640,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading